Insider · CIK 0001893955
Robert Eugene Kristal
Files at BRTX (BioRestorative Therapies, Inc.). First filing -, latest -.
Robert Eugene Kristal files SEC Form 4 as CFO at BRTX (BioRestorative Therapies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Eugene Kristal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Stock Optionderivative | +166,492 | $0.00 | $0 | 166,492 | Feb 19, 2025 |
Questions about Robert Eugene Kristal
Answered from the filings on this page, as of the latest one.
Is Robert Eugene Kristal buying or selling?
Robert Eugene Kristal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Eugene Kristal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Eugene Kristal has 0.
Where does Robert Eugene Kristal file Form 4?
Robert Eugene Kristal has filed Form 4 at BRTX (BioRestorative Therapies, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.